mTOR pathway: A current, up-to-date mini-review (Review)

  • Authors:
    • Paul Zarogoulidis
    • Sofia Lampaki
    • J. Francis Turner
    • Haidong Huang
    • Stylianos Kakolyris
    • Konstantinos Syrigos
    • Konstantinos Zarogoulidis
  • View Affiliations

  • Published online on: October 10, 2014     https://doi.org/10.3892/ol.2014.2608
  • Pages: 2367-2370
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mammalian target of rapamycin (mTOR) is a protein serine/threonine kinase that was initially identified as the cellular target of rapamycin. This kinase regulates cell growth, proliferation, motility and survival, as well as the gene transcription and protein synthesis that are activated in response to hormones, growth factors and nutrients. Results from preclinical studies have indicated that factors antagonizing the mTOR pathway exert an antitumor effect on lung cancer. Furthermore, primary clinical trials of mTOR inhibitors have demonstrated that the inhibitors may be effective against lung carcinoma. The present study explores the association between mTOR and lung carcinogenesis and describes the clinical trials of mTOR inhibitors.
View References

Related Articles

Journal Cover

November 2014
Volume 8 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Zarogoulidis, P., Lampaki, S., Turner, J.F., Huang, H., Kakolyris, S., Syrigos, K., & Zarogoulidis, K. (2014). mTOR pathway: A current, up-to-date mini-review (Review). Oncology Letters, 8, 2367-2370. https://doi.org/10.3892/ol.2014.2608
MLA
Zarogoulidis, P., Lampaki, S., Turner, J. F., Huang, H., Kakolyris, S., Syrigos, K., Zarogoulidis, K."mTOR pathway: A current, up-to-date mini-review (Review)". Oncology Letters 8.6 (2014): 2367-2370.
Chicago
Zarogoulidis, P., Lampaki, S., Turner, J. F., Huang, H., Kakolyris, S., Syrigos, K., Zarogoulidis, K."mTOR pathway: A current, up-to-date mini-review (Review)". Oncology Letters 8, no. 6 (2014): 2367-2370. https://doi.org/10.3892/ol.2014.2608